➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

Investigational Drugs with Clinical Trials for: Idiopathic Pulmonary Fibrosis

Email this page to a colleague

« Back to Dashboard

Drugname Indication
GLPG1205 Idiopathic Pulmonary Fibrosis
GBT440 Idiopathic Pulmonary Fibrosis
Simtuzumab Idiopathic Pulmonary Fibrosis
Lebrikizumab Idiopathic Pulmonary Fibrosis
BIBF1120 Idiopathic Pulmonary Fibrosis
DCC-2618 Idiopathic Pulmonary Fibrosis
SHR-1210 Idiopathic Pulmonary Fibrosis
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.